» Authors » Priyanka Shivdasani

Priyanka Shivdasani

Explore the profile of Priyanka Shivdasani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 1128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Nowak J, Yurgelun M, Bruce J, Rojas-Rudilla V, Hall D, Shivdasani P, et al.
J Mol Diagn . 2016 Nov; 19(1):84-91. PMID: 27863258
Mismatch repair protein deficiency (MMR-D) and high microsatellite instability (MSI-H) are features of Lynch syndrome-associated colorectal carcinomas and have implications in clinical management. We evaluate the ability of a targeted...
12.
Hwang D, Sholl L, Rojas-Rudilla V, Hall D, Shivdasani P, Garcia E, et al.
J Thorac Oncol . 2016 Feb; 11(4):496-503. PMID: 26829311
Introduction: Mucinous differentiation is observed in a subset of lung adenocarcinomas with unique clinical and pathological features, but the biology of these neoplasms is poorly understood. Methods: We apply targeted...
13.
Awad M, Oxnard G, Jackman D, Savukoski D, Hall D, Shivdasani P, et al.
J Clin Oncol . 2016 Jan; 34(7):721-30. PMID: 26729443
Purpose: Non-small-cell lung cancers (NSCLCs) harboring mutations in MET exon 14 and its flanking introns may respond to c-Met inhibitors. We sought to describe the clinical, pathologic, and genomic characteristics...
14.
Lee J, Sholl L, Lindeman N, Granter S, Laga A, Shivdasani P, et al.
Clin Epigenetics . 2015 Jul; 7:59. PMID: 26221190
Background: Recent developments in genomic sequencing have advanced our understanding of the mutations underlying human malignancy. Melanoma is a prototype of an aggressive, genetically heterogeneous cancer notorious for its biologic...
15.
Macconaill L, Garcia E, Shivdasani P, Ducar M, Adusumilli R, Breneiser M, et al.
J Mol Diagn . 2014 Aug; 16(6):660-72. PMID: 25157968
Ongoing cancer genome characterization studies continue to elucidate the spectrum of genomic abnormalities that drive many cancers, and in the clinical arena assessment of the driver genetic alterations in patients...